Bank of New York Mellon Corp - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 45 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2021$230,000
-8.7%
103,404
+1.9%
0.00%
Q4 2020$252,000
+13.5%
101,428
+12.5%
0.00%
Q3 2020$222,000
-30.4%
90,185
+0.4%
0.00%
Q2 2020$319,000
+117.0%
89,835
+20.2%
0.00%
Q1 2019$147,000
+56.4%
74,758
+4.6%
0.00%
Q4 2018$94,000
-46.6%
71,4630.0%0.00%
Q3 2018$176,000
-26.7%
71,463
-0.0%
0.00%
Q2 2018$240,000
-19.5%
71,464
+1.4%
0.00%
Q1 2018$298,000
+27.9%
70,4910.0%0.00%
Q4 2017$233,000
-14.0%
70,491
-0.5%
0.00%
Q3 2017$271,000
-16.1%
70,832
-3.4%
0.00%
Q2 2017$323,00073,3590.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Corrigan Financial, Inc. 302,252$102,7660.03%
Virtu Financial LLC 13,324$50.00%
Bleakley Financial Group, LLC 80,000$27,2000.00%
Beaird Harris Wealth Management, LLC 24,400$8,2960.00%
One Day In July LLC 10,000$3,4000.00%
Cubic Asset Management, LLC 10,000$3,4000.00%
WMS Partners, LLC 18,000$6,1200.00%
Simplicity Solutions, LLC 80,000$27,2000.00%
WELLS FARGO & COMPANY/MN 3,296$1,1210.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders